The START Center for Cancer Research - Logo

Newsroom

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

Leave a Comment / Newsroom /

The START Center for Cancer Research (“START”), the world’s largest early-phase community-based cancer trial site network, today announced the launch of the START Hope Hub, a powerful new digital patient and physician-focused platform that connects patients, caregivers, advocacy groups, and referring oncologists with quick access to START’s 720+ oncology clinical trials and informational resources. With […]

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials Read More »

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

Leave a Comment / Newsroom /

Partnership Will Launch Three New START Research Sites to Bring Early Phase Trials Closer to Patients in Major U.S. Communities The START Center for Cancer Research (“START”), and OneOncology today announced a strategic partnership to launch early phase clinical trial sites. The rollout includes the Los Angeles Cancer Network (LACN, California), The Center for Cancer

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials Read More »

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

Leave a Comment / Newsroom /

Major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials The START Center for Cancer Research (“START”), the world’s largest early-phase community-based oncology site network, today announced the dosing of the first U.S. participant in Moderna’s Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors Read More »

CURC

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

Leave a Comment / Newsroom /

START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials The START Center for Cancer Research (“START”), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research Center (“CURC”) the premier urologic clinical research site specializing in genitourinary (GU) oncology. This acquisition strengthens

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center Read More »

Malignant Hematology

The START Center for Cancer Research Expands its Capabilities to Support Early-Phase Hematological Cancer Trials

Leave a Comment / Newsroom /

Expansion Brings New Principal Investigators, Expanded Site Resources, and Accelerated Trial Initiation to Support Breakthrough Blood Cancer Therapies 10 December 2024 The START Center for Cancer Research (“START”), the world’s largest community-based early phase cancer trial site network, has announced the expansion of its capabilities to support early phase hematological cancer trials globally. This expansion

The START Center for Cancer Research Expands its Capabilities to Support Early-Phase Hematological Cancer Trials Read More »

Rioja

The START Center for Cancer Research and Fundación Rioja Salud Announce New Partnership to Further Expand Access to Early Phase Clinical Trials in Spain

Leave a Comment / Newsroom /

28 October 2024 The START Center for Cancer Research (“START”), a global leader in early-phase cancer clinical trials, today announced a new strategic partnership with the Fundación Rioja Salud, a foundation dedicated to (i) the promotion and protection of health, (ii) the training, teaching, research, development and innovation of Health Sciences and biotechnology, what includes

The START Center for Cancer Research and Fundación Rioja Salud Announce New Partnership to Further Expand Access to Early Phase Clinical Trials in Spain Read More »

START Dublin Building

First Dedicated Early Phase Oncology Clinical Trials Unit in Ireland opened by Minister Donohoe at the Mater Hospital

Leave a Comment / Newsroom /

START Dublin will offer patients with advanced cancer the opportunity to participate in cutting edge research and enhance the availability of new cancer drugs 14 October 2024 The Minister for Public Expenditure, NDP Delivery and Reform, Paschal Donohoe TD has today (Monday) officially opened START Dublin, the Republic of Ireland’s first dedicated Phase I Clinical

First Dedicated Early Phase Oncology Clinical Trials Unit in Ireland opened by Minister Donohoe at the Mater Hospital Read More »

Dr. Amita Patnaik

START’s Amita Patnaik, MD, FRCPC: One of PharmaVoice’s 100 Most Inspiring Leaders of 2024

Leave a Comment / Newsroom /

San Antonio, TX – October 8, 2024. The START Center for Cancer Research (“START”) proudly announces that Amita Patnaik, MD, FRCPC, has been named to the prestigious PharmaVoice 100 list as a “Cancer Care Visionary.” This annual award celebrates inspiring individuals in life sciences who are making a profound impact on the field and driving

START’s Amita Patnaik, MD, FRCPC: One of PharmaVoice’s 100 Most Inspiring Leaders of 2024 Read More »

Chris Takimoto

The START Center for Cancer Research Appoints Dr. Chris Takimoto as Chief Medical Officer

Leave a Comment / Newsroom /

Dr. Takimoto to propel scientific and medical strategies and advance START’s leadership in global early-phase cancer research San Antonio, TX – October 2, 2024. The START Center for Cancer Research (“START”) proudly announces the appointment of Chris H. Takimoto, MD, PhD, FACP, as its new Chief Medical Officer. Dr. Takimoto, a renowned physician-scientist, oncology drug

The START Center for Cancer Research Appoints Dr. Chris Takimoto as Chief Medical Officer Read More »

Power of Community Site Networks

START Announces Launch of Virtual Panel Series: “The Power of Community Site Networks: Advancing Science & Broadening Access to Early Phase Cancer Trials”

Leave a Comment / Newsroom /

New Series Unites Global Experts to Explore the Future of Oncology Research in Community Settings San Antonio, TX – August 29, 2024. The START Center for Cancer Research (“START”), the largest global network of fully dedicated, community-based, early-phase oncology clinical trial sites, is proud to announce the launch of its Virtual Panel Series, titled “The

START Announces Launch of Virtual Panel Series: “The Power of Community Site Networks: Advancing Science & Broadening Access to Early Phase Cancer Trials” Read More »

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Contact Us
Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.

Who We Serve

Services

About

Resources

START Locations

Patients & Family

Find a Trial
The START Center for Cancer Research - Logo

© 2025 START Research. All rights reserved.

Facebook Linkedin X-twitter